Tower Research Capital (TRC)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.8M | Buy |
375,994
+146,782
| +64% | +$7.95M | 0.54% | 23 |
|
|
2025
Q4 | $11.2M | Buy |
229,212
+209,102
| +1,040% | +$9.75M | 0.27% | 60 |
|
|
2025
Q3 | $868K | Buy |
20,110
+17,010
| +549% | +$664K | 0.02% | 574 |
|
|
2025
Q2 | $119K | Sell |
3,100
-11,727
| -79% | -$448K | ﹤0.01% | 2240 |
|
|
2025
Q1 | $574K | Buy |
14,827
+14,241
| +2,430% | +$521K | 0.02% | 758 |
|
|
2024
Q4 | $19.8K | Sell |
586
-24,468
| -98% | -$881K | ﹤0.01% | 3188 |
|
|
2024
Q3 | $1.02M | Sell |
25,054
-4,081
| -14% | -$167K | 0.03% | 521 |
|
|
2024
Q2 | $1.12M | Buy |
29,135
+19,919
| +216% | +$838K | 0.02% | 701 |
|
|
2024
Q1 | $395K | Buy |
9,216
+5,422
| +143% | +$224K | 0.01% | 1001 |
|
|
2023
Q4 | $141K | Buy |
3,794
+3,077
| +429% | +$110K | ﹤0.01% | 2365 |
|
|
2023
Q3 | $26K | Sell |
717
-1,392
| -66% | -$49.4K | ﹤0.01% | 3140 |
|
|
2023
Q2 | $75.2K | Buy |
2,109
+824
| +64% | +$29.6K | ﹤0.01% | 2257 |
|
|
2023
Q1 | $46K | Sell |
1,285
-1,710
| -57% | -$59.8K | ﹤0.01% | 2566 |
|
|
2022
Q4 | $105K | Sell |
2,995
-16,484
| -85% | -$549K | ﹤0.01% | 1799 |
|
|
2022
Q3 | $573K | Buy |
19,479
+15,721
| +418% | +$596K | 0.01% | 1037 |
|
|
2022
Q2 | $204K | Buy |
3,758
+3,756
| +187,800% | +$207K | ﹤0.01% | 1761 |
|
|
2022
Q1 | $0 | Sell |
2
-2,320
| -100% | -$126K | ﹤0.01% | 6265 |
|
|
2021
Q4 | $128K | Buy |
+2,322
| New | +$121K | ﹤0.01% | 2068 |
|
|
2021
Q3 | – | Sell |
-6,124
| Closed | -$305K | – | 5915 |
|
|
2021
Q2 | $305K | Sell |
6,124
-473
| -7% | -$22.7K | 0.01% | 1593 |
|
|
2021
Q1 | $295K | Sell |
6,597
-10,636
| -62% | -$483K | 0.01% | 1676 |
|
|
2020
Q4 | $793K | Buy |
17,233
+15,883
| +1,177% | +$730K | 0.02% | 649 |
|
|
2020
Q3 | $64K | Buy |
1,350
+1,161
| +614% | +$58.2K | ﹤0.01% | 3430 |
|
|
2020
Q2 | $10K | Sell |
189
-10,098
| -98% | -$518K | ﹤0.01% | 4008 |
|
|
2020
Q1 | $487K | Buy |
10,287
+10,073
| +4,707% | +$537K | 0.03% | 439 |
|
|
2019
Q4 | $13K | Sell |
214
-4,249
| -95% | -$236K | ﹤0.01% | 2201 |
|
|
2019
Q3 | $238K | Buy |
4,463
+3,301
| +284% | +$170K | 0.02% | 916 |
|
|
2019
Q2 | $58K | Sell |
1,162
-7,192
| -86% | -$361K | ﹤0.01% | 1503 |
|
|
2019
Q1 | $437K | Buy |
8,354
+8,274
| +10,343% | +$413K | 0.03% | 678 |
|
|
2018
Q4 | $4K | Sell |
80
-2,306
| -97% | -$114K | ﹤0.01% | 3029 |
|
|
2018
Q3 | $119K | Sell |
2,386
-354
| -13% | -$18K | 0.01% | 1246 |
|
|
2018
Q2 | $138K | Sell |
2,740
-16,831
| -86% | -$848K | 0.01% | 1242 |
|
|
2018
Q1 | $956K | Buy |
19,571
+19,411
| +12,132% | +$904K | 0.08% | 206 |
|
|
2017
Q4 | $7K | Buy |
160
+80
| +100% | +$3.7K | ﹤0.01% | 2737 |
|
|
2017
Q3 | $4K | Sell |
80
-381
| -83% | -$19.3K | ﹤0.01% | 3392 |
|
|
2017
Q2 | $25K | Sell |
461
-780
| -63% | -$41.6K | ﹤0.01% | 1101 |
|
|
2017
Q1 | $65K | Buy |
1,241
+1,214
| +4,496% | +$61.6K | 0.01% | 623 |
|
|
2016
Q4 | $1K | Sell |
27
-2,085
| -99% | -$103K | ﹤0.01% | 3607 |
|
|
2016
Q3 | $114K | Buy |
2,112
+570
| +37% | +$31.3K | 0.01% | 744 |
|
|
2016
Q2 | $84K | Buy |
1,542
+1,263
| +453% | +$66.5K | 0.01% | 1217 |
|
|
2016
Q1 | $14K | Buy |
+279
| New | +$13.9K | ﹤0.01% | 1622 |
|
|
2015
Q4 | – | Sell |
-608
| Closed | -$29K | – | 4691 |
|
|
2015
Q3 | $29K | Buy |
608
+470
| +341% | +$24.5K | ﹤0.01% | 1427 |
|
|
2015
Q2 | $7K | Buy |
138
+134
| +3,350% | +$7.54K | ﹤0.01% | 2994 |
|
|
2015
Q1 | $0 | Buy |
+4
| New | +$229 | ﹤0.01% | 4613 |
|
|
2014
Q4 | – | Sell |
-372
| Closed | -$22K | – | 4280 |
|
|
2014
Q3 | $22K | Buy |
372
+212
| +133% | +$13K | ﹤0.01% | 2226 |
|
|
2014
Q2 | $11K | Sell |
160
-3,402
| -96% | -$230K | ﹤0.01% | 2279 |
|
|
2014
Q1 | $238K | Buy |
3,562
+2,589
| +266% | +$175K | 0.03% | 365 |
|
|
2013
Q4 | $65K | Sell |
973
-153
| -14% | -$9.92K | 0.01% | 1177 |
|
|
2013
Q3 | $70K | Buy |
1,126
+678
| +151% | +$43.6K | 0.01% | 1617 |
|
|
2013
Q2 | $28K | Buy |
+448
| New | +$28.4K | ﹤0.01% | 1398 |
|
Other funds holding GSK
JEST
